Current Protein Identity:P24821 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1TEN STRUCTURE OF A FIBRONECTIN TYPE III DOMAIN FROM TENASCIN PHASED BY MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN Deposited 1992-08-28 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 802–891(90 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION mmCIF provides none of the parsed conditions Resolution 1.80 Å
2RB8 High resolution design of a protein loop Deposited 2007-09-18 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 802–893(92 aa) Fragment:unp residues 802-896
Mutation:M24F, P25K, S27L, Q28A, P29E, V30I, F33I No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;3.8M sodium formate, 5% glycerol, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 1.45 Å R-free 0.196
2RBL High resolution design of a protein loop Deposited 2007-09-19 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 802–893(92 aa) Fragment:unp residues 802-896
Chain B 802–893(92 aa) Fragment:unp residues 802-896
Mutation:M24F, P25K, S27L, Q28A, P29E, V30I, F33I Mutation:M24F, P25K, S27L, Q28A, P29E, V30I, F33I No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 3;298 K;2.0 M Ammonium Sulfate, pH = 3.0, 10% additive 0.1 M cupric chloride, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.300
2RBL High resolution design of a protein loop Deposited 2007-09-19 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain M 802–893(92 aa) Fragment:unp residues 802-896
Mutation:M24F, P25K, S27L, Q28A, P29E, V30I, F33I No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 3;298 K;2.0 M Ammonium Sulfate, pH = 3.0, 10% additive 0.1 M cupric chloride, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.10 Å R-free 0.300
6QNV Fibrinogen-like globe domain of Human Tenascin-C Deposited 2019-02-12 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1979–2196(218 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293.15 K;Morpheus 0.09M NPS, 0.1M Buffer System 3 pH = 8.5, 50% v/v Precipitant Mix 1
Resolution 1.40 Å R-free 0.182
8FN8 Crystal structure of the C-terminal Fg domain of TNC with the single FN domain of PTPRZ Deposited 2022-12-27 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1975–2201(227 aa) Fragment:Fg domain (UNP residues 1975-2201)
Not recorded CA CALCIUM ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;20% w/v PEG3350, 100 mM Tris-HCl, pH 8.0
Resolution 1.89 Å R-free 0.205
8FNB Crystal structure of the C-terminal Fg domain of human TNC with the mutations Y2140H and S2164H Deposited 2022-12-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1975–2201(227 aa) Fragment:Fg domain (UNP residues 1975-2201)
Mutation:Y2140H, S2164H CA CALCIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;200 mM lithium sulfate, 25% PEG1500, 50 mM Tris, pH 8.0
Resolution 1.80 Å R-free 0.174
8FNB Crystal structure of the C-terminal Fg domain of human TNC with the mutations Y2140H and S2164H Deposited 2022-12-27 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 1975–2201(227 aa) Fragment:Fg domain (UNP residues 1975-2201)
Mutation:Y2140H, S2164H CA CALCIUM ION × 1 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;200 mM lithium sulfate, 25% PEG1500, 50 mM Tris, pH 8.0
Resolution 1.80 Å R-free 0.174
9NIG PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide Deposited 2025-02-26 Assembly 1 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain P 1013–1024(12 aa) Fragment:residues 1013-1024
Non-standard monomer:Yes (specific site not provided by mmCIF) No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
Resolution 3.20 Å R-free 0.260
9NIG PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide Deposited 2025-02-26 Assembly 2 Protein heterocomplex Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain G 1013–1024(12 aa) Fragment:residues 1013-1024
Non-standard monomer:Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 EDO 1,2-ETHANEDIOL × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
Resolution 3.20 Å R-free 0.260
9NIG PB TCR in complex with HLA-DR4 presenting citrullinated Tenascin C peptide Deposited 2025-02-26 Assembly 3 Other combination Heteromer;Protein × 5 PDB declaration: pentameric(5) Consistent with protein count
Chain L 1013–1024(12 aa) Fragment:residues 1013-1024
Non-standard monomer:Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;293 K;0.1 M Tris pH7.5, 0.3M NaCl, 0.05 M Glutamic acid, 0.05M Arginine, 20% PEG3350
Resolution 3.20 Å R-free 0.260
9NIH Crystal structure of HLA-DR4 presenting citrullinated Tenascin C peptide Deposited 2025-02-26 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 1013–1024(12 aa) Fragment:residues 1013-1024
Non-standard monomer:Yes (specific site not provided by mmCIF) NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 GOL GLYCEROL × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.5;293 K;0.2 M NaCl, 0.1 M Bis Tris pH 5.5, 29% PEG3350
Resolution 2.40 Å R-free 0.219
9R5Y Crystal structure of the C-terminal domain of human TNC in complex with Adhiron 52 Deposited 2025-05-11 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1976–2193(218 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.4;291.15 K;10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.02 M sodium formate, 0.02 M ammonium acetate, 0.02 M trisodium citrate, 0.02 M sodium potassium l-tartrate, 0.02 M sodium oxamate, 0.1 M bicine/Trizma base pH 8.5
Resolution 1.40 Å R-free 0.185
9R5Y Crystal structure of the C-terminal domain of human TNC in complex with Adhiron 52 Deposited 2025-05-11 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 1976–2193(218 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.4;291.15 K;10% w/v PEG 20 000, 20% v/v PEG MME 550, 0.02 M sodium formate, 0.02 M ammonium acetate, 0.02 M trisodium citrate, 0.02 M sodium potassium l-tartrate, 0.02 M sodium oxamate, 0.1 M bicine/Trizma base pH 8.5
Resolution 1.40 Å R-free 0.185